Vertex Pharmaceuticals
OrganizationHeard in 3 episodes across 2 shows since Jul 2026
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotechnology firms to utilize an explicit strategy of rational drug design rather than combinatorial chemistry. The company focuses on developing and commercializing therapies for treating serious diseases, notably cystic fibrosis.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 2 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
What experts have said about Vertex Pharmaceuticals
5 statements · 2 positive · 3 neutral
Vertex agreed to acquire Crinetics for $10 billion in cash.
“Vertex has agreed to buy Crenex for $10 billion in cash.”
Open the episode · Micron and Sandisk Drop; SpaceX Rating; Crinetics SoarsListen at 3:54
The Crinetics acquisition will give Vertex entry into endocrinology.
“This will give Vertex an entry into the endocrinology market.”
Open the episode · Micron and Sandisk Drop; SpaceX Rating; Crinetics SoarsListen at 4:09
Vertex Pharmaceuticals agreed to acquire Kinetics Pharma for $85 per share.
“Vertex Pharmaceuticals agreeing to acquire kinetics Pharma for 85 bucks a share.”
Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf JumpsListen at 1:07
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring Vertex Pharmaceuticals, newest first
